Postpartum hemorrhage management in 2012: Predicting the future

Oluwatoyosi Onwuemene, David Green, Louis Keith*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Transfusion therapy in postpartum hemorrhage (PPH) traditionally has been modeled after precedents set in the Vietnam and Korean wars. However, data from recent military combat casualties suggest a different transfusion strategy. Transfusion of packed red blood cells, fresh frozen plasma, and platelets in a ratio of 1:1:1 improves dilutional coagulopathy and survival. Women who present with low fibrinogen at the time of diagnosis of PPH have poorer outcomes and might benefit from early fibrinogen replacement. The antifibrinolytic agent, tranexamic acid, decreases bleeding and progression to severe PPH, but its role in PPH management is evolving. Observational data suggest that the use of recombinant factor VIIa should be limited to bleeding that has not responded to an optimal transfusion strategy. Point-of-care testing using thromboelastography is helpful in guiding the selection of blood products to be transfused. Additionally, massive transfusion protocols can decrease the overall number of products transfused and improve outcomes.

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalInternational Journal of Gynecology and Obstetrics
Issue number1
StatePublished - Oct 2012


  • Fibrinogen
  • Hemorrhage
  • Massive transfusion protocol
  • Maternal morbidity
  • Maternal mortality
  • Postpartum hemorrhage
  • Tranexamic acid
  • Transfusion

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Postpartum hemorrhage management in 2012: Predicting the future'. Together they form a unique fingerprint.

Cite this